| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Common Stock | 25,000 | $654,367 | $26.17 | 17 Feb 2026 | Direct |
| Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Stock Option (right to buy) | 221,268 | 17 Feb 2026 | Direct | ||
| IO Biotech, Inc. | Director | Stock Option (Right to Buy) | 35,144 | 05 Jun 2025 | Direct | ||
| Kura Oncology, Inc. | Director | Option to purchase common stock | 28,500 | 05 Jun 2025 | Direct | ||
| Kura Oncology, Inc. | Director | Option to purchase common stock | 26,000 | 05 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | 17 Feb 2026 | 3 | -$1,066,262 | 4 | CHIEF MEDICAL OFFICER | 19 Feb 2026, 18:36 |
| ELVN | Enliven Therapeutics, Inc. | 12 Feb 2026 | 2 | $0 | 4 | CHIEF MEDICAL OFFICER | 17 Feb 2026, 19:47 |
| IOBT | IO Biotech, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:24 |
| KURA | Kura Oncology, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:05 |
| ELVN | Enliven Therapeutics, Inc. | 06 Feb 2025 | 1 | $0 | 4 | CHIEF MEDICAL OFFICER | 10 Feb 2025, 17:25 |
| ELVN | Enliven Therapeutics, Inc. | 18 Oct 2024 | 3 | -$22,459 | 4 | CHIEF MEDICAL OFFICER | 22 Oct 2024, 16:17 |
| IOBT | IO Biotech, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:12 |
| KURA | Kura Oncology, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:30 |
| ELVN | Enliven Therapeutics, Inc. | 11 Apr 2024 | 3 | -$451,878 | 4 | CHIEF MEDICAL OFFICER | 15 Apr 2024, 19:02 |
| ELVN | Enliven Therapeutics, Inc. | 13 Feb 2024 | 1 | $0 | 4 | CHIEF MEDICAL OFFICER | 15 Feb 2024, 20:46 |
| IOBT | IO Biotech, Inc. | 15 Nov 2023 | 1 | $0 | 4 | Director | 17 Nov 2023, 16:47 |
| IOBT | IO Biotech, Inc. | 09 Nov 2023 | 0 | $0 | 3 | Director | 17 Nov 2023, 16:41 |
| KURA | Kura Oncology, Inc. | 31 May 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 16:45 |
| ELVN | Enliven Therapeutics, Inc. | 04 Apr 2023 | 1 | $0 | 4 | Chief Medical Officer | 06 Apr 2023, 20:32 |
| ELVN | Enliven Therapeutics, Inc. | 23 Feb 2023 | 1 | $0 | 4 | Chief Medical Officer | 27 Feb 2023, 20:32 |
| ELVN | Enliven Therapeutics, Inc. | 23 Feb 2023 | 0 | $0 | 3 | Director | 27 Feb 2023, 20:25 |
| KURA | Kura Oncology, Inc. | 21 Jun 2022 | 1 | $0 | 4 | Director | 23 Jun 2022, 16:54 |
| KURA | Kura Oncology, Inc. | 28 Jul 2021 | 2 | $0 | 4 | Director | 29 Jul 2021, 17:17 |
| KURA | Kura Oncology, Inc. | 28 Jul 2021 | 0 | $0 | 3 | Director | 29 Jul 2021, 17:14 |